Cystic Fibrosis: all 1,605 studies
Page 12 of 17. Open to participants first (196), then studies with results posted, then the rest; newest registration first within each.
- Electrical Impedance Imaging of Patients With Cystic FibrosisCompletedNCT02524704
- Pro-resolving Effect of MAG-DHA in Cystic Fibrosis (PREMDIC)TerminatedNCT02518672Phase 2
- Investigating the Use of a Positive Parenting Programme to Improve Treatment Adherence in Cystic FibrosisCompletedNCT02501369Not applicable
- Efficacy and Safety of Inhaled Nitric Oxide (NO) in Cystic Fibrosis (CF) PatientsTerminatedNCT02498535Phase 2
- Antibiotic Nephrotoxicity in Adult Patients With Cystic FibrosisStatus unknownNCT02489955Not applicable
- Outpatient Antibiotic Treatment for a Cystic Fibrosis Pulmonary ExacerbationCompletedNCT02480270
- Inhaled Molgramostim (rhGM-CSF) in Healthy Adult SubjectsCompletedNCT02468908Phase 1
- Developing and Validating a Patient-reported Outcome Instrument to Monitor Symptom Management in Pulmonary Exacerbation in CFCompletedNCT02464267
- A Study of OligoG in Cystic Fibrosis Subjects With Burkholderia Spp. InfectionCompletedNCT02453789Phase 2
- Assessment of Cystic Fibrosis Lung Involvement With UTE Pulse SequencesCompletedNCT02449785Not applicable
- Observational Study in Cystic Fibrosis Patients Using TOBI® PODHALER® or Other FDA Approved Inhaled Antipseudomonal Antibacterial DrugsCompletedNCT02449031
- Observational Study of Outcomes in Cystic Fibrosis Patients With Selected Gating Mutations on a CFTR Allele (The VOCAL Study)CompletedNCT02445053
- Cystic Fibrosis Diagnosis by Analyzing Nasal BrushingStatus unknownNCT02433132Not applicable
- Home Monitoring to Predict Exacerbation in Cystic FibrosisCompletedNCT02416375
- A Multi-Center Study of the CF Quantum® Sweat Test SystemTerminatedNCT02404714
- Using Remote Telemonitoring to Detect Early Decline in Lung Function & Streamline Clinics in Adults With Cystic FibrosisCompletedNCT02399241Not applicable
- Role of Glucagon In Glucose Control in Cystic Fibrosis Related DiabetesCompletedNCT02398383Early Phase 1
- Saline Hypertonic in PreschoolersCompletedNCT02378467Not applicable
- Multiple Breath Nitrogen Washout in Healthy and Cystic Fibrosis ChildrenCompletedNCT02378454
- Multiple Breath Nitrogen Washout in Healthy and Cystic Fibrosis AdultsCompletedNCT02368080
- The Challenge of Obtaining Qualitative Bacterial Cultures in Non-expectorating Cystic Fibrosis PatientsCompletedNCT02363764
- FTIH - Single and Repeat Oral Doses of FDL169 in Healthy VolunteersCompletedNCT02359357Phase 1
- Respiratory Function at Preschool Age of Children Detected of Cystic Fibrosis in Neonatal PeriodCompletedNCT02358798Not applicable
- Clearing Lungs With Epithelial Sodium Channel (ENaC) Inhibition in Cystic Fibrosis (CF)CompletedNCT02343445Phase 2
- Comparison of Non-invasive Measurement Methods of Hepatic Fibrosis in Cystic FibrosisCompletedNCT02342964Not applicable
- Evaluation of the Lung Clearance IndexCompletedNCT02342951Not applicable
- Effect of Miglustat on the Nasal Potential Difference in Patients With Cystic Fibrosis Homozygous for the F508del MutationCompletedNCT02325362Phase 2/3
- Impact of Availability of Showerpatch for Patients With Intravenous CathetersTerminatedNCT02324868Not applicable
- Sputum Purulence as a Predictor of Cystic Fibrosis Exacerbations: a Prospective Cohort Trial.CompletedNCT02309229
- Impaired Secretory IgA and Mucosal Immunity in Cystic FibrosisStatus unknownNCT02308267
- Kinetics of YKL-40 Protein in Serum of Cystic Fibrosis PatientsCompletedNCT02305784
- Positive Expiratory Pressure During Inhalation of Hypertonic Saline in Patients With Cystic FibrosisCompletedNCT02303808Not applicable
- RATNO, Reducing Antibiotic Tolerance Using Nitric Oxide in CF - a Phase 2 Pilot StudyCompletedNCT02295566Phase 2
- Evaluation of Pharmacokinetic and Pharmacodynamic Properties of Intravenous Colistimethate SodiumCompletedNCT02288429
- Effect of a Nursing Program for Patients With Cystic Fibrosis on Disease ManagementCompletedNCT02286050Not applicable
- Gaming Console Home-Based Exercise for Adults With Cystic FibrosisCompletedNCT02277860Not applicable
- A Randomized-Controlled Trial of Inhaled Hypertonic Saline (7%) to Evaluate the Lung Clearance IndexCompletedNCT02276898Phase 2
- Study of N91115 in Patients With Cystic Fibrosis Homozygous F508del-CFTR MutationCompletedNCT02275936Phase 1
- Evaluation of a Therapeutic Strategy Including Nebulised Liposomal Amphotericin B (Ambisome®) in Maintenance Treatment of Allergic Bronchopulmonary Aspergillosis (Cystic Fibrosis Excluded).CompletedNCT02273661Phase 2
- Safety, Tolerability and Pharmacokinetics of BIIL 284 BS in Adult and Pediatric Cystic Fibrosis (CF) PatientsCompletedNCT02269189Phase 1
- Safety, Tolerability and Pharmacokinetics of Increasing Doses of BIIL 284 BS in Adult and Pediatric Cystic Fibrosis (CF) PatientsCompletedNCT02265679Phase 1
- HFN Versus NIV in Cystic Fibrosis. The HIFEN StudyCompletedNCT02262871Not applicable
- Resistive Inspiratory Manoeuvre as Airway Clearance Technique in Cystic FibrosisCompletedNCT02261987Not applicable
- Evaluation of the High Frequency Digit Triplet Test in Cystic FibrosisStatus unknownNCT02252601Not applicable
- DPP-IV Inhibition Prior to Development of Diabetes in Patients With Cystic FibrosisStatus unknownNCT02239458Not applicable
- Non Invasive Ventilation for Acute Exacerbations in Adult CFStatus unknownNCT02234401Not applicable
- Development of a New Tool for Dyspnea Measurement in Chronic Respiratory DiseasesCompletedNCT02229994
- PK Study of N91115 in Cystic Fibrosis PatientsCompletedNCT02227888Phase 1
- BioEnergetics and Metabolomics in Cystic FibrosisCompletedNCT02225899
- First Study of Oral Cysteamine in Cystic FibrosisCompletedNCT02212431Phase 1/2
- Glycemic Monitoring in Cystic FibrosisCompletedNCT02211235
- Breath Analysis in in Adults With Cystic Fibrosis (CF)CompletedNCT02209571Not applicable
- Social Determinants in Chronic Disease in British ColumbiaCompletedNCT02203084
- Redox Imbalance and the Development of Cystic Fibrosis DiabetesCompletedNCT02202876Not applicable
- Evaluation of the Timing of the Nebulization Related to the Physiotherapy SessionCompletedNCT02201082Not applicable
- The iStep Study: Development and Validation of an Incremental Exercise Step Test for Children With Cystic FibrosisCompletedNCT02199340Not applicable
- A Prospective, Multicenter, Collaborative Study to Determine the Prevalence of Nontuberculous Mycobacteria (NTM) in Pediatric Patients With Cystic Fibrosis in FloridaCompletedNCT02198079
- Ivacaftor in French Patients With Cystic Fibrosis and a G551D MutationCompletedNCT02194881
- Biomarkers of Iron Homeostasis and Responses to Cystic Fibrosis Pulmonary Exacerbation (CFPE) TreatmentCompletedNCT02188758
- Cystic Fibrosis Treatment Adherence Cayston Proof-of-Concept Pilot StudyCompletedNCT02179710
- Safety, Tolerability and Pharmacokinetics of Tiotropium in Cystic Fibrosis PatientsCompletedNCT02172534Phase 1
- A Phase IIb Study of OligoG in Subjects With Cystic FibrosisCompletedNCT02157922Phase 2
- Cystic Fibrosis Related DiabetesStatus unknownNCT02148978Not applicable
- Contraceptive Hormones and Women With Cystic FibrosisTerminatedNCT02144246Phase 1
- Safety Study of Fenretinide in Adult Patients With Cystic FibrosisCompletedNCT02141958Phase 1
- Energy Balance and Weight Gain With Ivacaftor TreatmentCompletedNCT02141464
- A Study of Lung Clearance After Hypertonic Saline Delivery Using the tPAD DeviceCompletedNCT02141191Phase 1
- The Effectiveness of a Systemic Mindfulness-based Intervention Program in a Cystic Fibrosis ClinicStatus unknownNCT02131857Not applicable
- Non Ivasive Prenatal Diagnosis (NIPD) of Cystic FibrosisStatus unknownNCT02130648
- Clinical Study With an Enteral Formula With Symbiotic and DHA for Malnourished ChildrenCompletedNCT02128984Not applicable
- Mapping Chemical and Microbiological Heterogeneity Throughout Explanted Cystic Fibrosis Lung SpecimensCompletedNCT02128711
- Effects of an Exercise Program Among CF Patients With DysglycemiaCompletedNCT02127957Not applicable
- Muco Smartphone ExacerbationCompletedNCT02122289Early Phase 1
- Evaluation of Inhaled Antibiotics on Bacterial Diversity and Richness in the Cystic Fibrosis LungTerminatedNCT02113397
- A Coaching Intervention to Young Adults With Cystic FibrosisCompletedNCT02110914Not applicable
- Pilot Observational Study to Determine Feasibility of a Standardized Treatment of Pulmonary Exacerb. in Patients With CFCompletedNCT02109822
- In Vitro Assessment of a Breath-synchronized Vibrating Mesh Nebulizer During Non Invasive VentilationCompletedNCT02084043Not applicable
- Evaluation of the Safety of the Medical Device Simeox®TerminatedNCT02061852Not applicable
- Breath Condensate Study in Patients With Cystic Fibrosis.CompletedNCT02056132
- Cystic Fibrosis- Children and Adults Tai Chi StudyCompletedNCT02054377Not applicable
- Impact of Immunonutrition on the Patients With Cystic FibrosisStatus unknownNCT02048592Phase 4
- Intermittent Versus Continuous Infusion Meropenem in Cystic FibrosisWithdrawnNCT02048163
- Increased Vitamin D Reduces Pulmonary Exacerbations in CFCompletedNCT02043717
- Ivacaftor (Kalydeco) and Insulin in Cystic Fibrosis (CF)CompletedNCT02039986
- Gender Disparity and Hormones in Cystic FibrosisCompletedNCT02036879Early Phase 1
- An Open-Label, Phase 1 Study in Healthy Adult Subjects to Examine the Effects of Multiple-Dose Ciprofloxacin on Ivacaftor and VX-661 in Combination With IvacaftorCompletedNCT02015507Phase 1
- Flaxseed Modulates Inflammation and Oxidative Stress in CFCompletedNCT02014181Phase 1
- Alpha1 Antitrypsin Aerosol Therapy in Cystic FibrosisTerminatedNCT02010411Phase 2
- Evaluating the Impact of Chronic Rhinosinusitis on the Health-Related Quality of Life Among Adults With Cystic FibrosisCompletedNCT02003079
- A Study to Investigate Lung Deposition of Radiolabelled OligoGCompletedNCT01991028Phase 2
- Effects Of Noninvasive Ventilation On Functional Capacity Of Patients With Cystic FibrosisCompletedNCT01987271Not applicable
- Investigating the Incretin Effect in Cystic FibrosisCompletedNCT01975259
- Viral Pathogenesis of Early Cystic Fibrosis Lung DiseaseCompletedNCT01973192
- Probiotics on Intestinal Inflammation in Cystic FibrosisCompletedNCT01961661Phase 3
- Evaluation of the Safety and Tolerability of Inhaled Nitric Oxide to Subjects With Cystic FibrosisCompletedNCT01958944Phase 1/2
- Pilot Study of Behavioural Intervention for Nutrition in Cystic FibrosisCompletedNCT01957072Not applicable
- Probiotics in Cystic FibrosisCompletedNCT01956916Phase 3
- Bioequivalence and Safety of Vantobra and TOBI in Healthy SubjectsCompletedNCT01953367Phase 1
- Long Term Significance (Survival) of LCI in Patients With Cystic FibrosisWithdrawnNCT01951833
- Phase 1 Study Assessing the Safety and Tolerability of CTX-4430 in Cystic Fibrosis PatientsCompletedNCT01944735Phase 1